High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: A reappraisal of prognostic factors

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: A reappraisal of prognostic factors'. Together they form a unique fingerprint.

Medicine & Life Sciences